Most hair care brands want to say something about hair that falls out, because that is what their buyers worry about. The trap is that the words which sell the feeling of a fuller head are the same words that cross into medicine, and once a product is read as a medicine it leaves the cosmetic register and enters a far stricter world of approval that most brands are not set up to enter.
This article sets out what a cosmetic claim can say about hair that sheds, how the law draws the line between care and medicine, which words push a product into drug or medical territory, what evidence supports a care claim, and why the pack and the product page must tell the same story. The aim is to keep a brand on the right side of the regulatory line without losing the message that sells the routine.
Why the hair-loss claim sits on a regulatory line
The line is not about the bottle, it is about the words on it. A serum and a drug can look alike, but the claim decides which rule book applies, and the claim is read by a reviewer the way a buyer reads it, by the plain meaning of the sentence rather than by the intent behind it.
A cosmetic is sold to cleanse, perfume, protect, keep in good condition, or change appearance. The moment a product is presented as changing how the body works, as making hair grow or as stopping a loss that is physical, it is read as acting on the body rather than on the look. That shift is what moves it from cosmetic to medicine, and the shift is made by wording.
The cost of crossing is steep. A medicine needs approval, safety data, and often a clinical file before sale; a cosmetic needs a safe formula and a substantiated claim. A brand that drifts across the line by a careless phrase takes on the medicine's burden with none of its preparation, and the product can be pulled from sale while the fix is written.
The safe habit is to write the claim for the eye and the hand, not for the follicle. Say what the user sees and feels, and leave the body's work to products that are cleared to do it. The cosmetic field is wide enough to hold a strong message without reaching across the boundary.
How cosmetic law draws the line between care and medicine
The test used in the main markets is the principal action. If the product works by changing the structure or function of the body, through a pharmacological, immunological or metabolic route, it is a medicine. If it works on the surface, by coating, cleansing or perfuming, it is a cosmetic. The same oil can sit on either side depending on what the brand says it does with it.
In the EU the cosmetic definition is set in Regulation 1223/2009, and a product whose main effect is pharmacological is excluded from the cosmetic register. A leave-on that merely conditions the strand softens the look of sparseness stays cosmetic; one positioned to stimulate growth does not. The claim, not the recipe, sets the category, which is why the wording is reviewed before the launch.
In the US the line runs between a cosmetic and a drug under the Federal Food, Drug, and Cosmetic Act. A product intended to affect the structure or function of the body, such as by promoting hair growth, is a drug and needs the drug route. A cosmetic may cleanse, beautify and condition, but it may not be presented as altering the body's growth, and the border is judged by the plain claim.
In China the position is sharper still, because anti-hair-loss is a special-use cosmetic that needs registration with the authority before sale, separate from ordinary cosmetic filing. The claim must be backed and must not state medical efficacy, so the Chinese brief is a registration brief, not only a formula brief. Our anti-hair-loss line manufacturer article covers how that category is built from the formula up.
What a cosmetic claim can actually say
A cosmetic claim about shedding hair lives in the language of appearance and feel. It can speak of the look of fuller hair, the strength of the strand against breakage, and the ease of combing without snap. Those are things a user can see and a test can measure, and they stay on the cosmetic side of the line without strain.
It can also name the cause it addresses in cosmetic terms. "Reduces breaking caused by combing" points at a mechanical event the product can influence, not at a bodily process it cannot. "Supports the look of density" describes what the eye reports, not what the root does. The wording keeps the claim where the law allows it, and the user still hears the benefit.
The claim can name a sensation too. "Scalp feels balanced" and "roots feel cared for" are feel claims that no reviewer reads as medicine, because they describe experience rather than bodily change. They are weaker in the advertisement, but they are safe, and safe is what lets a brand keep selling the product week after week.
The pattern is consistent: say what is seen, felt or measured on the surface, and avoid any word that says the body has been changed. The surface is a wide field; most brands can say enough there to sell without touching the forbidden ground, and the discipline is to stay on it by choice.
Words that cross into medical or drug territory
Some words are bright lines. "Stops hair loss", "regrows hair", "grows new hair" and "restores lost hair" all state a change in the body's growth, which is the definition of a drug claim in most markets. A brand that prints any of them has written a medicine label by accident, and the accident is still enforceable.
Other words are quieter traps. "Strengthens the root" can read as acting on the follicle rather than the strand; "nourishes the bulb" points below the surface; "blocks the hormone" is plainly pharmacological. Each moves the claim from the look to the body, and the move is what a reviewer catches, often long after the pack has been printed.
The test is simple to apply. If the word could only be true because the body changed, it is a medical or clinical claim and belongs to a medicine. If it could be true because the surface changed, it is a cosmetic claim and stays with the brand. "Fuller looking" passes; "fuller by growth" fails. Our allergen and labelling piece shows how wording is read against the rules in practice.
The risk is not only the regulator. A buyer who reads a growth promise and sees none feels misled, and a complaint travels faster than a launch. The careful claim protects the brand from its own customers as much as from the authority, because both read the same sentence the same way.
Proving a care claim with evidence
A claim is only as good as the file behind it. The common criteria used across markets ask that a cosmetic claim be backed by evidence suited to the claim, and a bare sentence on the pack with no study invites challenge. The evidence has three common shapes, and the right one follows the claim.
Instrument testing is the first. A device measures comb force before and after use, or counts shed strands caught on a comb, or images the strand diameter. These give numbers a reviewer can read, and they suit claims about breakage and strength rather than about growth, which a cosmetic may not claim in the first place.
Consumer testing is the second. A panel uses the product and scores feel and look on a scale, and the result supports claims about "looks fuller" or "feels stronger" when the scores move and the study is run blind. The panel size and the wording of the question decide whether the claim holds up, so the study is planned before the claim is written.
Image assessment is the third, and the most persuasive for a density claim. Standardised photographs of the parting are graded by trained assessors, and a measurable shift in the look of sparseness supports a cosmetic claim about appearance without touching the body. A brand that skips the file is guessing; one that builds it can defend the words when asked.
Claim wording that survives scrutiny
The safest claims are specific and surface-bound. "Reduces breaking from combing by up to X percent in a four-week user study" is long, but it names the event, the measure and the proof, and a reviewer can trace every word to the file. Vague claims are the ones that fall, because vagueness is where the line gets crossed by accident.
The wording should match the test. If the study measured comb breakage, the claim says comb breakage; if it measured look, the claim says look. A claim that reaches past the study, even by a friendly word, is unsupported, and unsupported is the same as false in a review. The claim is a report of the data, not an upgrade of it.
The phrasing should also stay in the present tense of appearance. "Hair looks thicker" survives; "hair becomes thick" risks a growth read. "Scalp feels refreshed" survives; "scalp is corrected" does not. The tense carries the category, and the careful writer keeps it cosmetic by keeping it in the visible and the felt.
The discipline is to write the claim from the evidence backwards. Start with what the study showed, then say exactly that, and resist the urge to round it up into a promise the data cannot carry. The rounded promise is the one that crosses the line, and it is the one a competitor will quote.
Labels and the e-commerce page must match
The pack and the product page are read as one claim, and a mismatch is a finding. A carton that says "looks fuller" next to a page that says "regrows hair" is not two messages, it is one contradictory claim, and the stronger word is the one the reviewer quotes. The page inherits the pack's duty, and the duty is the same across both.
The matching rule applies to images too. A before-and-after photo that implies growth, placed beside a cosmetic claim, pulls the whole listing into drug territory even if the words are careful. The picture is read before the sentence, and a picture of new hair is a growth claim made without words, which a reviewer will still read as a claim.
The rule also applies across languages. A claim translated for one market must keep the same boundary it had at home, because a softer word abroad can cross a line that the home wording cleared. The brief should fix the claim in every language before the art is drawn, not after a market rejects the listing and the cost of a reprint lands.
The practical step is a claim audit on the full listing, pack and page together, before launch. A brand that checks the words once and the picture once, in one pass, avoids the split claim that a competitor or a reviewer will spot first, and the audit is cheap against the cost of a pulled product.
Market-by-market differences that matter
The boundary is shared in principle but differs in detail, and the detail is where launches fail. The table sets out how the main markets read an anti-shedding claim, so the brief can name the markets before the words are written and the formula is locked to a claim it cannot support abroad.
| Market | Cosmetic reach | Claim examples allowed | Evidence expected |
|---|---|---|---|
| EU | Cosmetic claim for look and feel | Reduces comb breakage, looks fuller | Substantiation under Reg 655/2013 |
| US | Cosmetic versus drug split | Appearance and condition claims | Growth claim is a drug claim |
| China | Special-use cosmetic, registration | No medical efficacy wording | Registration file required |
| ASEAN | Cosmetic directive scope | Appearance claims supported | Substantiation per directive |
| UK | GB cosmetic rules, EU aligned | Look and feel claims | Substantiation expected |
| Japan | Cosmetic and quasi-drug split | Cosmetic limited to appearance | Quasi-drug route for more |
The table gives the direction rather than the full text, because each market publishes its own wording rules and they change. Our labelling requirements by market guide lists where each market publishes its rules. The claim that clears one column can fail another, and the brief should name every market before the pack is printed, not after the first rejection.
What to put in the brief
- The exact claim wording for pack and page, matched across both so they cannot contradict.
- The markets in scope, because each sets its own boundary and its own evidence bar.
- The evidence type behind the claim, instrument, consumer or image, named up front.
- The study result, so the wording can be written from it rather than around it.
- The words banned by category, listed before the copy is draft, not after review.
- The product page and pack art, audited together for words and pictures alike.
- The translation plan, so the boundary holds in every language on the listing.
- The claim owner, because a claim needs one accountable sign-off before launch.
Where our capability fits
We support an anti-shedding line as a cosmetic project, keeping every claim on the care side of the regulatory line. The formula is built for appearance and feel, the claim is written from the evidence, and the pack and page are audited together so the message holds in each market without a later rewrite.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development — whichever matches where your brand is today. Our care lines include a strengthening scalp essence spray and an anti-static leave-in spray, both positioned with cosmetic claims rather than medical ones.
Tell us the claim you must stay inside and the markets you will sell in, and we will show you the formula and the wording that hold the line. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319.
General manufacturing information, not regulatory or legal advice. Claim boundaries, registration duties and evidence rules vary by market and change over time; confirm with the authority before launch.